4//SEC Filing
Johnson Steven Andrew 4
Accession 0001181431-09-040976
CIK 0000849636other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 7:21 PM ET
Size
5.5 KB
Accession
0001181431-09-040976
Insider Transaction Report
Form 4
Johnson Steven Andrew
VP, Preclinical Development
Transactions
- Award
Options to Purchase Common Stock
2009-08-22+262,000→ 262,000 totalExercise: $0.20Exp: 2019-08-22→ Common Stock (262,000 underlying)
Footnotes (1)
- [F1]The option becomes vested and exercisable in three equal annual installments beginning on August 22, 2010.
Documents
Issuer
CORTEX PHARMACEUTICALS INC/DE/
CIK 0000849636
Entity typeother
Related Parties
1- filerCIK 0001389221
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 7:21 PM ET
- Size
- 5.5 KB